Atlas Trials

COVID-19 Antibody Responses in Cystic Fibrosis

Clinical trial NCT05614336 · COMPLETED

Trial details

NCT number
NCT05614336
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19Cystic Fibrosis
Start date
2022-06-15
Primary completion
2025-09-17
Enrollment
331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.